{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T11:15:14Z","timestamp":1787483714833,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.aohep.2026.102201","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:07:25Z","timestamp":1773335245000},"page":"102201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap"],"prefix":"10.1016","volume":"31","author":[{"given":"Leandro","family":"Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahana","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamak Modaresi","family":"Esfeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3207-2231","authenticated-orcid":false,"given":"Omar T.","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian J.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10457","key":"10.1016\/j.aohep.2026.102201_bib0001","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.aohep.2026.102201_bib0002","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","article-title":"Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(03)00283-6","article-title":"Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence","volume":"39","author":"Neuberger","year":"2003","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2026.102201_bib0004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0005","first-page":"66","article-title":"Primary biliary cirrhosis and liver transplantation","volume":"1","author":"Akamatsu","year":"2012","journal-title":"Intractable Rare Dis Res"},{"key":"10.1016\/j.aohep.2026.102201_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7831165","article-title":"Pretransplant evaluation and liver transplantation outcome in PBC patients","volume":"2022","author":"Mijic","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2026.102201_bib0007","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/apt.18134","article-title":"The overlap with metabolic dysfunction-associated steatotic liver disease negatively affects outcomes of primary biliary cholangitis","volume":"60","author":"Hern\u00e1ndez-P\u00e9rez","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2024.08.011","article-title":"Association of food insecurity with MASLD prevalence and liver-related mortality","volume":"82","author":"Younossi","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2026.102201_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","article-title":"Natural history of metabolic dysfunction-associated steatotic liver disease","volume":"122","author":"Lekakis","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.aohep.2026.102201_bib0010","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.aohep.2026.102201_bib0011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","year":"2024","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102201_bib0012","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00535-010-0249-x","article-title":"Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis","volume":"45","author":"Sorrentino","year":"2010","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.aohep.2026.102201_bib0014","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1111\/liv.16100","article-title":"Waitlist and transplant outcomes in patients with metabolic dysfunction-associated steatotic liver disease and autoimmune hepatitis","volume":"44","author":"Medina-Morales","year":"2024","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/lt.26531","article-title":"Waitlist and posttransplantation outcomes of lean indi- viduals with nonalcoholic fatty liver disease","volume":"29","author":"Ochoa-Allemant","year":"2023","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.aohep.2026.102201_bib0016","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults await- ing liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.aohep.2026.102201_bib0017","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.3390\/jcm13154497","article-title":"The external validation of GLOBE and UK-PBC risk scores for predicting ursodeoxycholic acid treatment response in a large U.S. cohort of primary biliary cholangitis patients","volume":"13","author":"Marenco-Flores","year":"2024","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.aohep.2026.102201_bib0018","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.dld.2022.12.010","article-title":"Treatment response to ursodeoxycholic acid in primary biliary cholangitis: a systematic review and meta-analysis","volume":"55","author":"Gazda","year":"2023","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.aohep.2026.102201_bib0019","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/liv.13644","article-title":"Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis","volume":"38","author":"Minuk","year":"2018","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.aohep.2026.102201_bib0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4254\/wjh.v16.i4.511","article-title":"Metabolic dysfunction-associated steatotic liver disease: a silent pandemic","volume":"16","author":"Samanta","year":"2024","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0021","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14527","article-title":"Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation","volume":"36","author":"Zhou","year":"2022","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.aohep.2026.102201_bib0022","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/tri.13814","article-title":"Disease-specific waitlist outcomes in liver transplantation - a retrospective study","volume":"34","author":"Nagai","year":"2021","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0023","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a frailty index based on direct physical performance measures for predicting mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2026.102201_bib0024","first-page":"200","article-title":"Performance-based measures associate with waitlist mortality in patients with cirrhosis independent of MELD","volume":"67","author":"Lai","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2026.102201_bib0025","first-page":"270","article-title":"Sarcopenia in patients with cirrhosis: implications for transplantation","volume":"20","author":"Montano-Loza","year":"2014","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.aohep.2026.102201_bib0026","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty predicts waitlist mortality in liver transplant candidates","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.aohep.2026.102201_bib0027","first-page":"e36","article-title":"A North American expert opinion statement on frailty in liver transplantation","volume":"103","author":"Carey","year":"2019","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.aohep.2026.102201_bib0028","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","year":"2019","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102201_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186990","article-title":"Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.aohep.2026.102201_bib0030","first-page":"341","article-title":"Frailty and prehabilitation in liver transplant candidates","volume":"25","author":"Dunn","year":"2021","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.aohep.2026.102201_bib0031","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1159\/000547227","article-title":"Comparable long-term liver transplant outcomes in PSC with and without MASLD: last decade analysis of the UNOS database","volume":"43","author":"Sierra","year":"2025","journal-title":"Dig Dis"},{"issue":"10","key":"10.1016\/j.aohep.2026.102201_bib0032","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"10.1016\/j.aohep.2026.102201_bib0033","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41574-022-00711-5","article-title":"Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation","volume":"18","author":"Lonardo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.aohep.2026.102201_bib0034","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/apt.12881","article-title":"The impact of type 2 diabetes and obesity on the long-term outcomes of >85 000 liver transplant recipients in the US","volume":"40","author":"Younossi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2026.102201_bib0035","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fmed.2020.00544","article-title":"Bile acids and FXR: novel targets for liver diseases","volume":"7","author":"Stofan","year":"2020","journal-title":"Front Med (Lausanne)"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268126000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:06:27Z","timestamp":1775181987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268126000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1665268126000220"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102201","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2026.102201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102201"}}